Company ProfilePremium

Huanxi Media Group Limited

Company Profile Analysis

Ticker: 1003.HK歡喜傳媒集團有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Huanxi Media Group Limited - Company showcase

Year Founded & Workforce

2015

50 Employees

Huanxi Media Group Limited logo

Huanxi Media Group Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Huanxi Media Group Limited Overview

Huanxi Media is an asset-light Chinese film and series investment house. Its original edge was ownership alignment: two of China's most bankable creators, director Ning Hao and actor-director Xu Zheng, are founding shareholders. Around them sits a roster of "shareholder directors" and contracted auteurs, including Zhang Yimou, Peter Chan, Wong Kar Wai, Zhang Yibai, Gu Changwei, Jia Zhangke, Wang Xiaoshuai and Chen Daming, who grant Huanxi priority or exclusive investment and new-media rights. The model is extremely hit-dependent. Full River Red (2023, RMB4.5bn+ box office) produced the only profitable year of the last five, and every other year produced losses. After two disappointing 2025 releases, a HK$498m FY2025 loss and a going-concern material-uncertainty paragraph, the company has repositioned as an "AI + film" story. It has raised HK$225m from new investor C River and tried to pivot toward AI-enabled production, but its Phancy (6682.HK) equity deal collapsed on 30 Sep 2026. It now has a 50-person team, no bank debt and a pipeline of unreleased films awaiting approval and release windows.


Company's own description (paraphrased from AR2025 and FY2025 results)

The company describes itself as an investment holding and film investment company. Its subsidiaries carry on media and entertainment businesses in two areas: developing and investing in film and TV programme rights, and operating an online video platform. Because PRC law restricts foreign ownership of internet audio-visual and certain media businesses, PRC operations are controlled through VIE contractual arrangements. The stated strategic creed is "Content is King" (內容為王). Since H2 2025 this has been paired with deploying AI in production and operations.

Independent characterisation

Huanxi is in substance a slate financier and lead producer ("主控出品") of a small number of premium theatrical films each year. Distribution is outsourced, with Maoyan Entertainment's group the dominant counterparty. Revenue has three sources:

  1. Share of box office income: the producer's net share after cinema, distributor and tax deductions. This is the dominant stream: 85% of FY2025 revenue and 97% of FY2023.

  2. Sub-licensing of film and TV rights: post-theatrical streaming, TV and new-media licences.

  3. Other media-related revenue: mainly the huanxi.com subscription platform, co-membership arrangements and related income. This stream has shrunk to HK$2.8m in FY2025.

A fourth line, film investment income/(loss), captures fair-value-type returns on minority film-rights investments carried at FVTPL.

A distinctive balance-sheet feature is "film investment funds from investors" (HK$430m at 30 Jun 2026). Third-party co-investors fund Huanxi-held film rights and recoup from theatrical income. These liabilities behave like project-level, performance-linked quasi-debt. They produce gains when films underperform (investors share losses) and losses when films outperform (as in FY2023, a HK$268m loss).

Revenue model mix

StreamFY2025% of gross revenue + investment income
Share of box office income (theatrical "product")286.983.9%
Sub-licensing of rights (licensing)47.513.9%
Other media revenue incl. platform (subscription/service)2.80.8%
Film investment income, net (investment)4.91.4%
Total342.1100%

Value-chain position, customers and end-markets

Position: Upstream content origination, financing and lead production. Huanxi does not own cinemas, does not distribute films itself, and has no material physical production assets (PP&E only HK$1.1m).

Customers: Distributors (the largest customer, a Maoyan group company, was 83.45% of FY2025 turnover; the top five were 98.70%), streaming platforms (licensees), and retail subscribers of huanxi.com.

Suppliers: Production companies, creative talent and licensors (the top five suppliers were 94.61% of FY2025 purchases; the largest was 37.03%).

End-markets: The PRC theatrical market (substantially all revenue) and the PRC online video (SVOD) market. Hong Kong houses the holding and finance functions.

Strategy

Stated strategy themes (AR2025 CEO statement; Interim 2026 Prospects)

  1. "Content is King" (內容為王): premium, genre-diverse films from top directors, with release timing managed against market conditions.

  2. "Intelligent film and television" transformation: AI in script development, filming support, post-production and VFX, introduced in phases.

  3. huanxi.com: curate global arthouse and festival titles and explore copyright partnerships.

  4. Prudent operation: cost control, streamlining of administrative costs and remuneration, and collection of receivables.

  5. Adjacencies: interactive entertainment, game development and IP-derivative products (named in use-of-proceeds disclosures).

Initiatives in the last 24 months

InitiativeDateDetailStatus (Oct 2026)
C River equity and warrant raiseNov 2025 – Apr 2026727.6m shares at HK$0.30 (gross HK$218.3m) + 731.3m warrants at HK$0.01 (gross HK$7.3m), exercisable at HK$0.44 for 5 years; net HK$225.1mCompleted 21 Apr 2026; HK$80.0m utilised by 30 Jun 2026
StepFun (上海階躍星辰) strategic cooperationNov 2025JV-platform framework covering data cooperation and large-model exploration in film creation, interactive entertainment, games, IP derivatives and AI animationFramework only; no JV formation disclosed
Phancy Group (6682.HK) partnership19 May 2026(i) Subscription of 731.3m shares at HK$0.275 (HK$201.1m gross; would have been 14.30% of enlarged capital); (ii) strategic cooperation and JV framework; (iii) first Large Model API agreement of US$20m over 2 years, prepaid; (iv) target of ≥US$200m of token-based API spend over 3 yearsShare subscription terminated 30 Sep 2026. Status of the API and framework agreements after termination is not disclosed in sources reviewed.
Cost programmeFY2025 – H1 2026Headcount 85 → 50; H1 2026 administrative expenses down 33.5% YoY; management remuneration adjustmentOngoing
Release-timing disciplineH1 2026Theatrical release of new films suspended amid weak market conditionsOngoing
Bye-law modernisationApr–Jun 2026Electronic communications and voting, treasury-share flexibilityApproved at the 9 Jun 2026 AGM
ESGFY2025Carbon-neutrality target of 2050; GHG emissions down 16%Reported

Use of C River proceeds

UseAllocatedUtilisedUnutilisedTarget date
AI team60.0060.0Dec 2026
AI hardware20.0020.0Dec 2026
AI software/applications20.0020.0Dec 2026
Film/TV rights (≥1 PRC title)50.042.27.8Dec 2026
General working capital75.137.837.3Dec 2026
Total225.180.0145.1—

Guidance and medium-term targets

Huanxi provides no quantitative financial guidance or medium-term targets. Qualitative guidance: Li Na is "expected to contribute revenue and improve the Group's performance"; release dates depend on approvals, market conditions and distribution; and AI benefits will take time. Profit or loss "alerts" under Rule 13.09 (for example, the 21 Aug 2026 reduction-in-loss announcement, which estimated a loss of HK$39–41m) are the only numeric forward indications.

Products & Services

The group sells individual films, web series and platform access rather than continuing product lines. The catalog below is organised by release status. Pricing of individual titles is not disclosed; box office numbers are total PRC gross, not Huanxi's share.

Released theatrical films and series (selected, attributable to Huanxi as investor or producer)

TitleDirector / key talentYearHuanxi rolePerformance / noteSource
Dying to Survive (我不是藥神)Wen Muye; co-produced by Ning Hao & Xu Zheng2,018Theatrical slateRMB3.1bn box officeAR2025; THR
Ash Is Purest White (江湖兒女)Jia Zhangke2,018Theatrical slateCannes 2018 competitionTHR; AR2025
Crazy Alien (瘋狂的外星人)Ning Hao; Huang Bo, Shen Teng2019 (CNY)Exclusive investorRMB2.2bn box office; RMB2.8bn minimum guarantee; RMB700m revenue to groupAR2025
Lost in Russia (囧媽)Xu Zheng2020 (CNY)Producer/rightsPremiered online via ByteDance platformsAR2025; uSmart
Leap (奪冠)Peter Chan; Gong Li2,020Producer, exclusive new-media rightsNational Day 2020 releaseAR2025; uSmart
One Second (一秒鐘)Zhang Yimou2,020ProducerReleased 2020AR2025
Run For Young (風犬少年的天空) — web seriesZhang Yibai2,020Exclusive investorSimulcast on huanxi.com and BilibiliAR2025; uSmart
尋漢計Tang Danian; Ren SuxiH1 2021ProducerTheatricalInterim 2021
Are You Lonesome Tonight? (熱帶往事)Wen Shipei; produced by Ning HaoH1 2021Co-producerTheatricalInterim 2021
Full River Red (滿江紅)Zhang Yimou; Jackson Yee, Shen Teng22 Jan 2023Investor & lead producerRMB4.5bn+ box office; China's #1 film of 2023; drove the FY2023 profitAR2023; AR2025
Papa (學爸)Su Liang; Huang Bo2,023InvestorHanna Pictures cooperationAR2025
The Movie Emperor (紅毯先生)Ning Hao; Andy LauQ1 2024Investor & producerThe only FY2024 release; FY2024 box office share HK$63.6mAR2025; FY2025 results
She's Got No Name (醬園弄·懸案)Peter Chan; Zhang Ziyi, Lei Jiayin21 Jun 2025Investor & lead producerAbout RMB375m box office vs. RMB550m reported two-part budget; Part II pendingWorld Journal; AR2025
The Stage (戲台)Chen Peisi; Huang Bo2,025Investor & lead producerBelow expectations per managementAR2025

Pipeline (status as of H1 2026 interim report)

TitleDirector / castStatusExpected timingSource
Li Na (獨自·上場)Peter Chan; Hu Ge, Vincent Cassel, Hao LeiCompleted; release licence application in progress"When appropriate"; earlier guided to 2026Interim 2026; AR2025
Unspoken (以父親之名), formerly 無所畏懼Chen Daming; Zhang HanyuPost-production / approvalsEarlier guided to 2026Interim 2026
Intercross (人魚)Cheng Er; Wang Yibo, Wang ChuanjunParticipating investor; approvalsTo be determinedInterim 2026
Deep In The Mountains (如意飯店)Li Yongyi; Qiao Shan, Wang Yanhui, Yang ZishanPost-production / approvalsTo be determinedInterim 2026
Full River Red II (滿江紅II)Zhang YimouEarly conceptual development; discussions continuing—Interim 2026
The Mountain (上山)Produced by Wang XiaoshuaiCompletedEarlier guided to 2026AR2025 appendix
Call Me Crazy (刺猬)Gu Changwei; Ge You, Karry WangCompleted per FY2023 results—FY2023 results
Strangers When We Meet (朝雲暮雨)Zhang Guoli; Zhou DongyuCompleted per FY2023 results—FY2023 results
Evacuate From The 21st Century (從21世紀安全撤離)Li Yang; Zhang RuoyunInvested per FY2023 results—FY2023 results
Paradise Guesthouse (天堂旅館) — 12-episode web seriesWong Kar Wai (producer/co-director)Development—AR2025 appendix
She's Got No Name Part IIPeter ChanNot formally announced—World Journal

Rights and pipeline contracts (the "director roster")

CounterpartyKey rights to Huanxi (summarised from AR2025 appendix)
Ning Hao (shareholder director)Founding partner; directed Crazy Alien and The Movie Emperor
Xu Zheng (shareholder director)Founding partner; Lost in Russia
Peter Chan (shareholder director)Investment right in at least 2 films, up to 60% of each budget; priority on global exclusive new-media licences
Wong Kar Wai (shareholder director)Exclusive investment in an 18-episode, two-season web series; 10-year global new-media rights
Zhang Yibai (shareholder director)Priority investment of ≥55% in at least 2 productions; exclusive rights to two web-series seasons
Gu Changwei (shareholder director)Exclusive investment in two web-series seasons; priority film investment
Zhang Yimou (shareholder director)Exclusive investment in 3 web series; one convertible into a priority film right at ≥60% of budget
Huang Bo / Hanna PicturesCo-investment and development (from June 2021)
Chen DamingPriority investment in at least 3 productions; two web-series seasons
Jia ZhangkeExclusive or priority investment in at least 3 new films; exclusive new-media rights
Wang XiaoshuaiPriority investment in 2 productions; global new-media exclusivity
Manfred WongPriority investment in at least 4 productions

huanxi.com (歡喜首映) online video platform

Description: A subscription-based, advertising-free premium SVOD service for PC, mobile and TV, operated through the VIE licence holder Beijing Hangaohua. It carries Huanxi originals plus curated arthouse and festival imports.

2025–2026 acquisitions: Eiffel, My Brothers and I, Incredible But True, The Braves (2025); Being Towards Death, I Swear, The Butcher's Blade (H1 2026); planned additions The Rental, The Woman Who Ran, Hinterland and The Forger.

Distribution partners (historical): Bilibili (dedicated channel), Maoyan, ByteDance, Huawei Video, Xiaomi, Mango TV, XGIMI, Skyworth, Hisense, and China Mobile (digital cinema, 2021).

Scale (historical, company-sourced): 1.2m paying subscribers (2019, Hollywood Reporter); more than 35m app downloads and more than 10m cumulative paying users by H1 2021 (uSmart). Current subscriber numbers are not publicly disclosed.

Pricing: Not publicly disclosed in sources reviewed.

Financial weight: "Other media revenue" fell from HK$48.1m (FY2021) to HK$2.8m (FY2025). This implies the platform is now commercially marginal.

AI-enabled production initiative (new, 2025–2026)

Scope: AI applications in script development, filming support, post-production VFX and "customised content for directors". Management also intends to explore interactive entertainment, game development and IP derivatives.

Funding: HK$100m of C River proceeds earmarked for AI: HK$60m for an AI team, HK$20m for hardware and HK$20m for software. All of it was unutilised at 30 Jun 2026.

Launch status: No commercial AI product has been launched. Management says the initiative is "early stage" and that its financial contribution will take time.

Financial Narrative

Income statement

Sources: FY2025, FY2023 and FY2022 results announcements. FY2021 operating and pre-tax income from TipRanks; FY2021 net loss confirmed by the FY2022 results (HK$235.557m). FY2025 aggregator EBITDA is derived from etnet's -29.742% EBITDA margin. The two EBITDA definitions diverge sharply; see commentary.

Margins (%)

The FY2021 gross margin comes from etnet; TipRanks reports a different FY2021 gross loss (HK$119.8m), so this figure is a source discrepancy and should not be relied on.

Revenue CAGR FY2021–FY2025: about 21.2% per year (158.4 → 342.1). This is not a meaningful growth indicator, because revenue swings by roughly 100x depending on whether a hit is released (FY2022: HK$13.6m; FY2023: HK$1,333m).

Half-year P&L (HK$ m)

Key expense lines by nature (HK$ m)

Commentary — P&L.

FY2023 was the inflection: Full River Red generated HK$1.29bn of box office share and a 68% gross margin. Even so, net profit was only HK$159m. Three items absorbed the gross profit: HK$319m of P&A spend, a HK$268m loss on investor-fund arrangements (co-investors took a share of the upside), and HK$106m of forward-looking impairments.

FY2024 revenue collapsed: to HK$34m with a single release, The Movie Emperor. A HK$51m film-investment loss deepened the hole.

FY2025 shows the structural problem: revenue rose 10x to HK$342m on two releases, but cost of revenue of HK$580m exceeded it. That cost included HK$396m of amortisation, and the two films missed expectations. On top came a HK$184.5m impairment as expected revenues on the remaining library were cut, and a HK$63.7m credit impairment. The result was the largest loss in the period, HK$498m.

H1 2026: The company deliberately released nothing. Revenue fell 97% and the loss narrowed 61%, helped by a HK$17.7m (33%) reduction in administrative expenses. This is a holding pattern, not a recovery.

Balance sheet

Sources: results announcements for FY2021–FY2025. FY2021 cash from etnet's cash-flow page (Stockopedia shows HK$119m, which may include other short-term items). FY2021 working capital from Stockopedia current assets (1,338) less current liabilities (578). No goodwill is recognised in any filing reviewed. FY2021 NAV per share is derived from equity and 3,656m shares.

30 June 2026 snapshot (HK$ m): total assets 1,620.4; cash 260.9; film rights 906.0; prepayments for rights 347.9; borrowings nil; lease liabilities 9.5; film investment funds from investors 430.3; total equity 907.6; net current assets 184.4; current ratio 1.27.

Commentary — balance sheet.

Equity erosion: Equity fell 58% from HK$1.66bn (FY2021) to HK$0.70bn (FY2025) before the April 2026 equity injection.

Content assets are written down, not monetised: Film rights shrank from HK$1.33bn (FY2023) to HK$0.84bn (FY2025). Completed rights fell from HK$930m to HK$506m in FY2025 alone, through amortisation of the two releases plus HK$127.6m of impairment on completed titles.

No bank leverage, but meaningful quasi-debt: The group carries HK$430m of investor funds. HK$230.3m of this, owed to a single investor, was originally due on 30 Jun 2026 and remains under negotiation.

Receivables quality is poor: HK$93.5m of trade payables are aged over 365 days, and most net trade receivables are also older than 365 days. Combined trade and other receivable loss allowances reached HK$83.5m in FY2025.

Cash flow

Source: etnet cash-flow summary derived from annual reports. Capex is not separately broken out in the sources reviewed, but PP&E balances of HK$1–2m imply capex is immaterial, so the FCF proxy is close to OCF. A 2021 buyback of 33.15m shares was reported by uSmart, but its value was not disclosed. No buybacks occurred in FY2023 or FY2025 per the filings; FY2022 and FY2024 are taken from the absence of any disclosed buyback.

Commentary — cash flow. Cash generation is lumpy and mostly negative. Production cash goes out years before release, and box office cash arrives 3–9 months after release. The large FY2021 operating outflow (HK$470m) was the build-up of the Full River Red, Li Na and She's Got No Name slate, funded mainly by FY2021 financing inflows of HK$441m. The aggregator's weighted-average share count also rose from 3.25bn (FY2020) to 3.60bn (FY2021), which suggests share issuance. Cash fell from HK$310m (FY2023) to HK$88m (FY2025) before the C River proceeds lifted it to HK$261m at H1 2026.

Ratios

The cash conversion cycle is not publicly disclosed and is not meaningful for a film-rights business, which has no inventory and very long-dated receivables and payables. Net debt/EBITDA is mathematically defined for FY2022, FY2024 and FY2025 only because both inputs are negative, so it has no analytical meaning in those years. Only FY2023 (net cash of about 1.3x EBITDA) is interpretable.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRoleOwnership / controlSource

Huanxi Media Group Limited (Bermuda)

Listed holdco; investment holding and film investment

Listed

AR2025

Beijing Huan Sheng Xiao Yu Culture Media Co. (北京歡聲笑語)

PRC WFOE; exclusive services provider to the VIE

Wholly owned

AR2025

Beijing Huanxi Shou Ying Culture Co. (北京歡喜首映) — VIE

Film/TV production and investment; GM is ED Hu Hui

100% registered to Ni Kelu, controlled via contracts

AR2025

Beijing Hangaohua Network Technology Co. (北京漢高華)

Holds the internet audio-visual programme service licences; operates the platform

80% VIE / 20% Gu Haibin

AR2025

Qingdao Huanxi Shou Ying

Former VIE subsidiary

Deregistered 21 Aug 2024

AR2025

Joint operations (two films)

Co-production arrangements

50%–55% participating interests; carrying value HK$110.3m (FY2025)

FY2025 note 14(e)

Revenue stream (HKD Mn)

Revenue stream (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Share of box office income

—01,292.563.6286.9

Sub-licensing of film/TV rights

—4.383.815.647.5

Other media-related revenue (incl. platform)

48.112.135.85.82.8

Film investment income/(loss), net

—-2.7-79.3-50.84.9

Total revenue + film investment income

158.413.61,332.834.2342.1

Revenue stream (%)

Revenue stream (%)FY2022FY2023FY2024FY2025

Share of box office income

097.0186.083.9

Sub-licensing

31.26.345.513.9

Other media revenue

88.82.717.00.8

Film investment income/(loss)

-20.0-6.0-148.61.4

Revenue stream YoY (%)

Revenue stream YoY (%)FY2023FY2024FY2025

Share of box office income

—-95.1351.2

Sub-licensing

1,867.7-81.4205.1

Other media revenue

196.0-83.7-52.6

Total

9,678.4-97.4900.8

Revenue stream (HKD Mn) (Half-Yearly)

Revenue stream (HKD Mn)H1 2025H1 2026

Share of box office income

144.51.6

Sub-licensing

30.90.2

Other media revenue

1.23.8

Film investment income

3.30.1

Total

179.95.7

Income Statement and Per-Share Data

Metric (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Revenue + film investment income, net

158.413.61,332.834.2342.1

Cost of revenue

—-106.3-426.5-219.3-580.1

Gross profit/(loss)

—-92.6906.3-185.1-238.0

Selling & distribution costs

—-5.6-319.4-83.7-156.6

Administrative expenses

—-123.3-138.2-122.3-120.1

Gain/(loss) on film investment funds from investors

—0-268.2112.156.9

Operating income

-222.4-221.2212.9-273.9-507.9

EBITDA (operating income + depreciation & intangible amortisation; film amortisation treated as content cost)

—-205.1226.5-260.3-497.3

EBITDA (aggregator, TipRanks/etnet basis incl. film amortisation add-back)

20.3-117.3519.8-38.7-101.7

Pre-tax income

-220.0-223.3212.1-272.0-508.2

Income tax (expense)/credit

—1.5-53.011.29.8

Net income attributable to owners

-235.6-221.8159.1-260.8-498.3

EPS basic (HKD)

-0.07-0.060.04-0.07-0.14

EPS diluted (HKD)

-0.07-0.060.04-0.07-0.14

Dividend per share (HKD)

00000

Margin (%)

Margin (%)FY2021FY2022FY2023FY2024FY2025

Gross margin

-38.6-679.568.0-541.7-69.6

Operating margin

-140.5-1,623.016.0-801.5-148.5

EBITDA margin (dossier definition)

—-1,504.817.0-761.6-145.4

Net margin

-148.8-1,627.411.9-763.1-145.7

Income Statement and Key Financials (HKD)

Metric (HKD Mn)H1 2025H1 2026

Revenue + film investment income

179.95.7

Gross loss

-17.6-3.9

Selling & distribution

-54.3-0.2

Administrative expenses

-52.8-35.1

Operating loss

-100.7-40.2

Net loss

-102.2-40.1

LPS (HKD)

-0.03-0.01

Expense (HKD Mn)

Expense (HKD Mn)FY2022FY2023FY2024FY2025

Amortisation of film/TV rights

84.0289.1219.1395.6

Impairment of film/TV rights

6.1106.20.2184.5

Impairment of financial & contract assets

8.53.421.963.7

Advertising & marketing

5.6319.483.7156.6

Employee benefits (ex-directors)

56.348.446.254.9

Directors' remuneration

21.338.623.321.1

Balance Sheet and Per-Share Data

Metric (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Total assets

2,261.72,210.32,234.21,948.21,387.7

Cash & cash equivalents

115.453.6310.1145.088.1

Film & TV programme rights (net)

—937.81,334.01,275.7841.1

Prepayments for film & TV rights

—813.7387.2359.6335.7

Bank/other borrowings — short-term

—108.3000

Bank/other borrowings — long-term

—0042.40

Lease liabilities (total)

—29.917.914.38.7

Net debt (borrowings + leases − cash)

—84.6-292.3-88.2-79.4

Film investment funds from investors (quasi-debt)

—524.5535.2519.0437.0

Total liabilities

606.4881.9780.7793.7691.1

Total equity

1,655.31,328.41,453.61,154.4696.6

Goodwill

00000

Intangible assets (ex-film rights)

—0000

Net current assets (working capital)

760654.4735.5474.033.3

NAV per share (HKD)

0.450.360.400.320.19

Cash Flow

Metric (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Operating cash flow

-469.5-46.4364.3-189.7-45.5

Net investing cash flow

-0.34.123.11.40.1

Free cash flow (proxy: OCF + net investing)

-469.8-42.3387.4-188.3-45.4

Net financing cash flow

440.6-13.3-128.328.6-16.1

Dividends paid

00000

Share buybacks (HKD Mn)

—0000

Net change in cash

-29.3-55.6259.1-159.7-61.5

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE (%, net income / average equity)

-15.2-14.911.4-20.0-53.8

ROA (%, net income / average assets)

-11.8-9.97.2-12.5-29.9

ROCE (%, etnet; proxy for ROIC)

-14.0-16.310.9-21.4-68.1

Current ratio (x)

2.311.771.951.651.05

Total debt / equity (%, etnet incl. leases)

7.410.41.24.91.2

Gearing (borrowings / (equity + borrowings), company definition)

—0.0800.040

Net debt / EBITDA (x, dossier EBITDA; negative = net cash or negative EBITDA)

—-0.41-1.290.340.16

Interest coverage (x, operating income / finance costs; negative = not meaningful)

—-37.543.2-487.4-301.8

Asset turnover (x, revenue / average assets)

0.080.010.600.020.21

Total liabilities / total assets (%)

26.839.934.940.749.8

Revenue by Region

Region (HKD Mn)FY2023FY2024FY2025

Total group revenue + investment income

1,332.834.2342.1

Revenue by Region and Region Assets & Liabilities

Metric (HKD Mn)FY2024FY2025

VIE group revenue + film investment income (incl. intra-group)

14.766.4

VIE group assets

435.7353.7

Share Price History

DatePriceContextSource

24 Jan 2020

+43% intraday

Lost in Russia online premiere

uSmart

Early 2024

About 0.57–0.71

—

Moomoo news snippets

11 Nov 2025

0.385 close

C River signing date

FY2025 results

19 May 2026

0.275 close (5-day average 0.249)

Phancy signing date

Interim 2026

20 May 2026

0.315 (open +14.55%)

AI partnership reaction

Zhitong Finance

Mid-2026 (latest observed)

0.196–0.214

etnet quotes (03 Jul 2026 and undated snapshots)

etnet

Valuation Snapshot

MultipleValueBasis

Market cap

≈HK$877m

4,384.1m shares × 0.20

Enterprise value (ex-investor funds)

≈HK$625m

Market cap − cash 260.9 + leases 9.5 (H1 2026)

EV including film investment funds

≈HK$1,056m

  • HK$430.3m quasi-debt

EV/Sales (FY2025)

≈1.8x

625 / 342.1

EV/Sales (TTM)

≈3.7x

TTM revenue ≈HK$167.8m

P/B

≈0.95x

NAV/share HK$0.21 (H1 2026)

Share Count (m) and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Shares in issue, year-end (m)

3,656.53,656.53,656.53,656.53,656.5

Weighted average shares (m)

3,6003,656.53,656.53,656.53,656.5

EPS (HKD)

-0.07-0.060.04-0.07-0.14

NAV per share (HKD)

0.450.360.400.320.19

DPS (HKD)

00000

Analyst Conclusions

Management guidance

  • No numeric guidance.

  • Release dates for Li Na, Intercross and Deep in the Mountains depend on approvals, market conditions and distribution.

  • AI tools will be introduced in phases, with the financial impact delayed.

  • Cost control continues.

  • The Full River Red II discussions with Zhang Yimou continue.

Consensus

Not available (no coverage).

Bull case

  1. One hit resets the equity story. FY2023 showed a single Zhang Yimou tentpole can deliver HK$1.29bn of box office share. At a market cap of about HK$0.9bn, a credible Li Na or Full River Red II success is a step-change.

  2. The balance sheet has been de-risked. Cash is HK$261m, there is no bank debt, and the FY2025 impairments (HK$184.5m) have already reset carrying values. P/B is about 0.95x.

  3. Costs are now structurally lower. H1 2026 administrative expenses ran at about HK$70m annualised versus HK$120m in FY2025, which lowers the break-even revenue required.

Bear case

  1. Hit dependence without hits. Four loss years in five, a 2025 slate that missed expectations, and zero releases in H1 2026. Library impairment risk persists on HK$906m of film rights.

  2. Liquidity overhang. HK$230.3m owed to one investor is past its original due date. The Phancy HK$201m equity has fallen away. The FY2025 going-concern uncertainty may recur in the FY2026 audit.

  3. The AI narrative is unproven and losing partners. None of the HK$100m AI budget had been deployed by H1 2026. The Phancy partnership's equity leg failed, and the US$20m API commitment's funding source is unclear.

Catalysts and monitorables (next 12 months)

  • Li Na release licence and release date.

  • Resolution of the HK$230.3m investor-fund liability (conversion into other films, settlement or extension).

  • Post-termination status of the Phancy JV and API agreements, and whether a replacement investor emerges.

  • Deployment of the AI budget by December 2026, as committed.

  • Full River Red II production start.

  • FY2026 audit opinion (going concern), expected around March 2027.

  • Chairman appointment.

  • Share price relative to the HK$0.44 warrant exercise price and the HK$0.30 C River entry price.

  • Changes in Maoyan's and Bilibili's holdings; activity by C River, which could become a 28.5% holder.

Analyst verdict

Huanxi Media is, at its core, a venture-style option on a handful of premium Chinese films, wrapped in a listed shell with a thin operating base. Its founding thesis is still visible in the 2025 Annual Report's director appendix: equity alignment with China's most bankable directors produces proprietary access to hits. That thesis was validated spectacularly once, with Full River Red in 2023. It has failed to repeat. The FY2025 slate turned HK$342m of revenue into a HK$498m loss, revealing how much P&A, amortisation and investor revenue-sharing absorb even in release years, and how quickly library values must be written down when a film disappoints.

The 2025–2026 response has been coherent but not yet convincing. The company shrank the team, stopped releasing into a weak market, raised HK$225m from C River at HK$0.30 and recast itself as an "AI + film" platform. But the AI pillar has no deployed capital, no disclosed output, and has just lost its second strategic partner's equity commitment. Meanwhile, a HK$230m investor liability sits past due. Governance has also weakened: there is no chairman, a founder breached dealing rules, and the founders' private studios compete for the same talent pipeline.

At roughly book value, the market is pricing the existing library and cash at par and assigning little value to the pipeline. This is not irrational. Li Na has been waiting for approval for years, and Full River Red II is only at concept stage. The verdict is speculative and catalyst-dependent: an avoid for fundamental, income or quality mandates, and a watchlist name for event-driven investors. The re-rating triggers are binary and observable: a Li Na release with credible box office, settlement of the investor-fund liability, and evidence of AI spending translating into lower production costs. Absent these, further dilution, impairment and going-concern scrutiny are the base case.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedAge (AR2025)Background / educationShareholding (31 Dec 2025)

Xiang Shaokun, Steven (項紹琨)

Executive Director & CEO

ED 2 Sep 2015; CEO 18 Sep 2015

63

Former partner at Weil, Gotshal & Manges (led China practice from 2004) and Clifford Chance Shanghai (2002–04); M&A specialist (counsel to Lenovo on the IBM PC acquisition); JD Vanderbilt; BA Beijing University of International Relations; admitted in New York and Hong Kong

Not listed in directors' interests

Hu Hui (呼惠)

Executive Director

27 Jul 2025

48

GM of Beijing Huanxi Shou Ying since 2014; producer of The Stage, She's Got No Name and Full River Red; formerly at Poly Huayi, Beida Huayi, Zhonglian Jinghua and ChinaVision Media (now Damai Entertainment, 1060.HK); BA English, Beijing Foreign Studies University

8,480,000 shares (0.23%)

Jiang Meng (姜萌)

Executive Director

18 Jun 2026

———

Ning Hao (寧浩)

Non-Executive Director

2 Sep 2015

48

Film director/screenwriter (Crazy Stone, Breakup Buddies, Crazy Alien); Beijing Film Academy (photography, 2003)

438,625,528 via Pacific Wits (12.00% pre-dilution); deemed 34.99% as concert party

Xu Zheng (徐崢)

Non-Executive Director

2 Sep 2015

53

Actor/director (Lost in Thailand, Lost in Russia); Golden Horse Best Actor for Dying to Survive; Shanghai Theatre Academy (1994)

438,625,528 via Tairong (12.00% pre-dilution); deemed 34.99%

Wong Tak Chuen (黃德銓)

INED; Audit Committee Chair

10 Apr 2014

61

FCPA (HKICPA), FCA (ICAEW); practising CPA; formerly INED of Eternity Investment, China Healthwise and Man Sang

—

Li Xiaolong (李小龍)

INED

2 Sep 2015

60

Founder and chairman of Net 263 Ltd. (002467.SZ); former independent director of Dangdang and KongZhong; Beijing University of Technology

15,060,000 (0.41%) via Panfaith

Wang Hong (王虹)

INED; Remuneration & Nomination Committee Chair

2 Sep 2019

61

VP of Hengdian Group; former chairman of Hengdian Film & TV Production (Monkey King: Hero is Back); former CEO of Asian Union New Media; UIBE economics (1988)

200,000 (jointly with spouse)

Song Pengliang (宋鵬亮)

INED

18 Jun 2026

———

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext

27 Jul 2025

Dong Ping resigns as Chairman, ED and member of the RemCo and NomCo; Hu Hui appointed ED and to the RemCo and NomCo

Chairman seat left vacant; deviation from CG Code C.2.1 for 2025

15 Sep 2025

Li Ni resigns as NED

Reason not given in sources reviewed

18 Jun 2026

Jiang Meng appointed ED; Song Pengliang appointed INED

Board expanded to 9 (3 ED / 2 NED / 4 INED)

10 Aug 2026

Remuneration Committee reconstituted (one appointment and one resignation effective 10 Aug 2026)

Names not captured in sources reviewed

Directors' Remuneration

Metric (HKD Mn)FY2022FY2023FY2024FY2025H1 2026

Total directors' remuneration

21.338.623.321.16.6

Shareholding Trend

HolderShares% at 31 Dec 2025Pro-forma % post-Apr 2026 (assumes no other changes)Source

C River Limited (affiliate of C River Co, Cayman)

727,638,000016.60

Interim 2026

Pacific Wits Ltd (Ning Hao)

438,625,52812.0010.00

AR2025

Tairong Holdings Ltd (Xu Zheng)

438,625,52812.0010.00

AR2025

Dong Ping (direct + Newwood 265.2m + Numerous Joy 92.3m + Highrise 0.8m)

402,063,29811.009.17

AR2025

Bilibili Inc.

328,366,9548.987.49

AR2025 (notified 31 Dec 2024)

Maoyan Entertainment

208,430,0005.704.75

AR2025 (disclosed 14 Oct 2022)

Li Xiaolong (Panfaith)

15,060,0000.410.34

AR2025

Hu Hui

8,480,0000.230.19

AR2025

Concert party under the 2015 shareholders' agreement (Dong, Ning, Xu and vehicles)

1,279,314,354

34.99

29.18

AR2025

Competitive Landscape

Key Competitors

CompetitorListingOverlap with HuanxiRelative positioning

Maoyan Entertainment

1896.HK

Film investment and distribution; also Huanxi's key distributor and a shareholder

Far larger and more diversified (ticketing, distribution); partner-competitor

Damai Entertainment (formerly Alibaba Pictures)

1060.HK

Film investment and production, distribution, IP

Backed by Alibaba; much larger platform and data assets

Lemon Film & TV (Ningmeng)

9857.HK

Film and series production

Larger series business

Straw Bear Entertainment

2125.HK

Series and film production

Series-weighted

Bona Film Group

001330.SZ

Film production/investment, cinemas

Vertically integrated (cinemas)

Wanda Film

002739.SZ

Production, distribution, cinemas

China's largest cinema chain

China Film Co.

600977.SH

State-owned production, distribution, exhibition

Policy-favoured; dominant distributor

Huayi Brothers

300027.SZ

Film production

Director-alliance model similar to Huanxi's; also financially stressed

Enlight Media

300251.SZ

Film production (animation; the Ne Zha franchise)

Animation leader

iQIYI / Tencent Video / Youku / Mango TV

IQ (NASDAQ); 700.HK; BABA; 300413.SZ

SVOD, competing with huanxi.com

Orders of magnitude larger; huanxi.com is niche

Founder-affiliated studios (Ning Hao's 壞猴子 entities; Xu Zheng's 真樂道 entities)

Private

Directors' own production companies (disclosed as competing interests)

Potential conflict: talent can route projects outside Huanxi

Competitor Detail

MetricHuanxi (FY2025)

Revenue

HK$342m

Revenue growth YoY

+900.8%

Gross margin

-69.6%

Net margin

-145.7%

Recent Developments

--

Company Snapshot

50

Employees

2015

Founded

Hamilton HM, Bermuda

Headquarters

SWOT Analysis

Strengths

  • Hit-making capability: Full River Red grossed more than RMB4.5bn and was China's #1 film in 2023, producing FY2023 gross profit of HK$906m (FY2023 results).
  • Elite talent alignment: Ning Hao and Xu Zheng each own 10.0% post-dilution. Contracts with Zhang Yimou, Peter Chan, Wong Kar Wai and others grant priority investment rights of up to 60% per film (AR2025 appendix).
  • No bank debt: Borrowings were nil at 31 Dec 2025 and 30 Jun 2026, and gearing is nil (Interim 2026).
  • Restored liquidity: Cash rose from HK$88.1m (FY2025) to HK$260.9m (H1 2026) after the C River proceeds. The current ratio improved from 1.05 to 1.27.
  • Lean cost base: Full-time headcount fell from 85 to 50, and H1 2026 administrative expenses fell to HK$35.1m from HK$52.8m (Interim 2026).
  • Strategic shareholder ecosystem: Bilibili (7.5%), Maoyan (4.75%) and C River (16.6%) are on the register, providing distribution and capital links (AR2025; Interim 2026).

Weaknesses

  • Chronic losses: Net losses in four of five years, totalling HK$1.22bn of losses for FY2021, FY2022, FY2024 and FY2025 against one profit of HK$159m.
  • Going-concern material uncertainty in the FY2025 auditor's report (PwC).
  • Revenue volatility: Revenue ranged from HK$13.6m (FY2022) to HK$1,333m (FY2023), and fell 97% in H1 2026.
  • Customer concentration: The largest customer (Maoyan group) was 83.45% of FY2025 turnover, and the top five were 98.70% (AR2025).
  • Governance gaps: The chair has been vacant since July 2025; there was a founder Model Code breach (Jul–Aug 2025); and two INEDs have more than nine years' tenure.
  • Platform erosion: Other media revenue fell from HK$48.1m (FY2021) to HK$2.8m (FY2025).

Opportunities

  • Li Na release: Peter Chan, Hu Ge and Vincent Cassel; completed, with the licence application in progress. Management expects a revenue contribution (Interim 2026).
  • Full River Red II with Zhang Yimou: a sequel to the 2023 #1 film (in early concept).
  • Library monetisation: Contract liabilities of HK$102.3m (H1 2026) represent advances for sub-licensing that will convert to revenue.
  • AI production efficiency: HK$100m earmarked; scope includes VFX and post-production cost reduction.
  • Warrant exercise: 731.3m warrants at HK$0.44 could raise about HK$321.8m if the share price recovers above the exercise price.
  • Policy support: The "Film Economy Promotion Year" and ticket subsidies (AR2025 outlook).

Threats

  • HK$230.3m investor-fund liability past its 30 Jun 2026 due date and under negotiation (Interim 2026 note 15).
  • Collapse of the Phancy deal (30 Sep 2026) removes HK$201m of expected equity and may jeopardise the AI API plan.
  • Weak PRC theatrical demand: H1 2026 box office declined and recovery is "slower than expected" (Interim 2026).
  • Approval and regulatory risk: The long-delayed Li Na licence; VIE structure enforceability (AR2025 risk factors).
  • Further impairments: Film rights of HK$906m remain on the balance sheet after FY2025 impairments of HK$184.5m.
  • Dilution: Warrants could add 16.7% to the share count; the 2024 option scheme mandate is 365.6m shares; and the stock trades below the C River price (about HK$0.20 vs. HK$0.30).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
3 Jun 2025She's Got No Name named opening film of the 27th Shanghai IFFMarketing lift for the key 2025 release
21 Jun 2025She's Got No Name opens nationwideAbout RMB375m gross; below expectations; two-part strategy questioned
Summer 2025Second 2025 release; management says it also fell short of expectations
27 Jul 2025Co-founder and Chairman Dong Ping resigns; Hu Hui appointed EDLeadership transition; chair left vacant
30 Jul – 21 Aug 2025Newwood (Dong) sells 119.37m shares (3.26%) during the blackout periodFounder sell-down; Model Code breach attributed to the concert party
29 Aug 2025H1 2025 results: revenue HK$179.9m (+56.2%), loss HK$102.2m (+14.8%)Losses persist despite releases
15 Sep 2025NED Li Ni resignsBoard contraction
19 Sep 2025Interim Report 2025 published—
9 Oct 2025Announcement on Model Code non-complianceGovernance controversy
Late Oct 2025She's Got No Name screens in the Tokyo IFF Gala section; Peter Chan attends without the castMedia read this as reputational fallout from the weak release
11 Nov 2025C River share and warrant subscription; StepFun AI cooperation announcedCapital raise and pivot to "AI + film"
12 Nov 2025Terms amended (shares 548.5m → 727.6m; warrants 1.889bn → 731.3m); trading haltedRestructured deal
13 Nov 2025Trading resumes—
22 Dec 2025SGM circular—
8 Jan 2026SGM approves the C River subscription and warrants—
Mar 2026HK$84.8m of subscription proceeds received earlyLiquidity bridge
24 Mar 2026Profit warning: FY2025 loss of about HK$498m—
31 Mar 2026FY2025 results; auditor's material uncertainty on going concernKey risk flag
21 Apr 2026C River completion: 727.6m shares and 731.3m warrants issued; shares in issue 4,384.1mHK$225.1m net proceeds
24 Apr 2026Bye-law amendments proposedHousekeeping and treasury shares
29 Apr 2026Annual Report 2025 and AGM circular—
19 May 2026Phancy subscription, JV framework and US$20m API agreementsSecond AI strategic investor (now failed)
20 May 2026Shares open up 14.6% to HK$0.315Market response to the AI news
21 May 2026A 16.6% shareholding deposited with Soochow Securities InternationalPossible financing or pledge by a holder (unconfirmed)
9 Jun 2026AGM: new bye-laws adopted; directors re-elected—
18 Jun 2026Jiang Meng (ED) and Song Pengliang (INED) appointedBoard refresh
22 Jun 2026Supplemental announcement on the INED appointment—
30 Jun 2026HK$230.3m owed to a film investor falls due; terms "still under negotiation"Unresolved liability
18/20 Jul 2026Phancy long-stop date extended to 30 Sep 2026Signals difficulty with conditions
10 Aug 2026Remuneration Committee membership change—
13 Aug 2026Board meeting notice for interim results—
21 Aug 2026"Reduction in loss" announcement (H1 loss HK$39–41m)—
28 Aug 2026H1 2026 results: revenue HK$5.7m; loss HK$40.1m; cash HK$260.9mNo releases; cost cuts working
11 Sep 2026Interim Report 2026 published—
30 Sep 2026Phancy subscription terminatedLoss of HK$201m expected funding; AI plan at risk
2 Oct 2026September Monthly Return: shares unchanged at 4,384.1m; warrants outstandingConfirms termination

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

7 charts
Income Statement: Revenue & Gross Profit: Revenue + film investment income, net rose from HKD 158.4 Mn in FY2021 to HKD 342.1 Mn in FY2025.
Huanxi Media Group Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue + film investment income, net158.413.61,332.834.2342.1
Cost of revenue—-106.3-426.5-219.3-580.1
Gross profit/—-92.6906.3-185.1-238

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.